Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms, Male

Explore clinical trials studying Breast Neoplasms, Male. Study availability and eligibility vary by location and protocol.

213 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms, Male trial results

Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +5 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Western Reg MC-COH Phoenix Goodyear, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 229 locations
View Trial Details
Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

NCT06492616

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
View all 555 locations
View Trial Details
Recruiting

ETHAN - ET for Male BC

NCT05501704

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Recruiting

MALE Mamm Organoids

NCT06786663

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +4 more
Locations
  • IRCCS National Cancer Institute "Regina Elena" Rome, Italy
View Trial Details
Completed

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

NCT00861705

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 448 locations
View Trial Details
Completed

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

NCT02206334

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 78 locations
View Trial Details

Related conditions